150 related articles for article (PubMed ID: 26087186)
21. MicroRNA-205 inhibits cancer cell migration and invasion via modulation of centromere protein F regulating pathways in prostate cancer.
Nishikawa R; Goto Y; Kurozumi A; Matsushita R; Enokida H; Kojima S; Naya Y; Nakagawa M; Ichikawa T; Seki N
Int J Urol; 2015 Sep; 22(9):867-77. PubMed ID: 26059417
[TBL] [Abstract][Full Text] [Related]
22. Golgi phosphoprotein 3 regulates metastasis of prostate cancer via matrix metalloproteinase 9.
Li W; Qi K; Wang Z; Gu M; Chen G; Guo F; Wang Z
Int J Clin Exp Pathol; 2015; 8(4):3691-700. PubMed ID: 26097550
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of cortactin and SIRT1 expression attenuates migration and invasion of prostate cancer DU145 cells.
Nakane K; Fujita Y; Terazawa R; Atsumi Y; Kato T; Nozawa Y; Deguchi T; Ito M
Int J Urol; 2012 Jan; 19(1):71-9. PubMed ID: 22050448
[TBL] [Abstract][Full Text] [Related]
24. Up-regulation of CXCR4 expression in PC-3 cells by stromal-derived factor-1alpha (CXCL12) increases endothelial adhesion and transendothelial migration: role of MEK/ERK signaling pathway-dependent NF-kappaB activation.
Kukreja P; Abdel-Mageed AB; Mondal D; Liu K; Agrawal KC
Cancer Res; 2005 Nov; 65(21):9891-8. PubMed ID: 16267013
[TBL] [Abstract][Full Text] [Related]
25. CXCL12/CXCR4 signaling activates Akt-1 and MMP-9 expression in prostate cancer cells: the role of bone microenvironment-associated CXCL12.
Chinni SR; Sivalogan S; Dong Z; Filho JC; Deng X; Bonfil RD; Cher ML
Prostate; 2006 Jan; 66(1):32-48. PubMed ID: 16114056
[TBL] [Abstract][Full Text] [Related]
26. Low TLR9 expression defines an aggressive subtype of triple-negative breast cancer.
Tuomela J; Sandholm J; Karihtala P; Ilvesaro J; Vuopala KS; Kauppila JH; Kauppila S; Chen D; Pressey C; Härkönen P; Harris KW; Graves D; Auvinen PK; Soini Y; Jukkola-Vuorinen A; Selander KS
Breast Cancer Res Treat; 2012 Sep; 135(2):481-93. PubMed ID: 22847512
[TBL] [Abstract][Full Text] [Related]
27. Emodin inhibits invasion and migration of prostate and lung cancer cells by downregulating the expression of chemokine receptor CXCR4.
Ok S; Kim SM; Kim C; Nam D; Shim BS; Kim SH; Ahn KS; Choi SH; Ahn KS
Immunopharmacol Immunotoxicol; 2012 Oct; 34(5):768-78. PubMed ID: 22299827
[TBL] [Abstract][Full Text] [Related]
28. Over-expression of lipocalin 2 promotes cell migration and invasion through activating ERK signaling to increase SLUG expression in prostate cancer.
Ding G; Fang J; Tong S; Qu L; Jiang H; Ding Q; Liu J
Prostate; 2015 Jun; 75(9):957-68. PubMed ID: 25728945
[TBL] [Abstract][Full Text] [Related]
29. The tumour-promoting receptor tyrosine kinase, EphB4, regulates expression of integrin-β8 in prostate cancer cells.
Mertens-Walker I; Fernandini BC; Maharaj MS; Rockstroh A; Nelson CC; Herington AC; Stephenson SA
BMC Cancer; 2015 Mar; 15():164. PubMed ID: 25886373
[TBL] [Abstract][Full Text] [Related]
30. CrkI and p130(Cas) complex regulates the migration and invasion of prostate cancer cells.
Dai Y; Qi L; Zhang X; Li Y; Chen M; Zu X
Cell Biochem Funct; 2011 Dec; 29(8):625-9. PubMed ID: 22144090
[TBL] [Abstract][Full Text] [Related]
31. Grancalcin (GCA) modulates Toll-like receptor 9 (TLR9) mediated signaling through its direct interaction with TLR9.
Kim TW; Hong S; Talukder AH; Pascual V; Liu YJ
Eur J Immunol; 2016 Mar; 46(3):712-24. PubMed ID: 26648480
[TBL] [Abstract][Full Text] [Related]
32. HOXC8 inhibits androgen receptor signaling in human prostate cancer cells by inhibiting SRC-3 recruitment to direct androgen target genes.
Axlund SD; Lambert JR; Nordeen SK
Mol Cancer Res; 2010 Dec; 8(12):1643-55. PubMed ID: 21047772
[TBL] [Abstract][Full Text] [Related]
33. Plumbagin elicits differential proteomic responses mainly involving cell cycle, apoptosis, autophagy, and epithelial-to-mesenchymal transition pathways in human prostate cancer PC-3 and DU145 cells.
Qiu JX; Zhou ZW; He ZX; Zhao RJ; Zhang X; Yang L; Zhou SF; Mao ZF
Drug Des Devel Ther; 2015; 9():349-417. PubMed ID: 25609920
[TBL] [Abstract][Full Text] [Related]
34. PBK/TOPK enhances aggressive phenotype in prostate cancer via β-catenin-TCF/LEF-mediated matrix metalloproteinases production and invasion.
Brown-Clay JD; Shenoy DN; Timofeeva O; Kallakury BV; Nandi AK; Banerjee PP
Oncotarget; 2015 Jun; 6(17):15594-609. PubMed ID: 25909225
[TBL] [Abstract][Full Text] [Related]
35. Study of TLR3, TLR4, and TLR9 in prostate carcinomas and their association with biochemical recurrence.
González-Reyes S; Fernández JM; González LO; Aguirre A; Suárez A; González JM; Escaff S; Vizoso FJ
Cancer Immunol Immunother; 2011 Feb; 60(2):217-26. PubMed ID: 20978888
[TBL] [Abstract][Full Text] [Related]
36. Connexin 43 expression is associated with increased malignancy in prostate cancer cell lines and functions to promote migration.
Zhang A; Hitomi M; Bar-Shain N; Dalimov Z; Ellis L; Velpula KK; Fraizer GC; Gourdie RG; Lathia JD
Oncotarget; 2015 May; 6(13):11640-51. PubMed ID: 25960544
[TBL] [Abstract][Full Text] [Related]
37. Comparative Proteomics Uncovers Correlated Signaling Network and Potential Biomarkers for Progression of Prostate Cancer.
Ai J; Lu Y; Wei Q; Li H
Cell Physiol Biochem; 2017; 41(1):1-9. PubMed ID: 28437789
[TBL] [Abstract][Full Text] [Related]
38. Potential role of CXCR3 in proliferation and invasion of prostate cancer cells.
Shen D; Cao X
Int J Clin Exp Pathol; 2015; 8(7):8091-8. PubMed ID: 26339376
[TBL] [Abstract][Full Text] [Related]
39. Clinical significance of toll-like receptor 3, 4, and 9 in gastric cancer.
Fernandez-Garcia B; Eiró N; González-Reyes S; González L; Aguirre A; González LO; Del Casar JM; García-Muñiz JL; Vizoso FJ
J Immunother; 2014; 37(2):77-83. PubMed ID: 24509170
[TBL] [Abstract][Full Text] [Related]
40. [The highly expressed secreted phosphoprotein 1 gene in prostate cancer metastasis: a microarray-based bioinformatic analysis].
Li TQ; Teng YL; Zou YG; Yang Y; Li Q; Mao XM
Zhonghua Nan Ke Xue; 2014 Nov; 20(11):984-90. PubMed ID: 25577832
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
